Raleigh, NC (PRWEB) June 19, 2013
Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, today announced it will be exhibiting and showcasing its technology at DIA 2013 (booth #2000) in Boston, June 24-26, 2013. Clinverse’s eClinical Commerce Network is the industry’s first and only fully configurable, cloud-based clinical financial lifecycle system.
Clinverse’s patent-pending technology, ClinPay®, the flagship module within Clinverse’s eClinical Commerce Network, automates site contract set-up and management, contract term translation, investigator payments and all the GAAP accounting and financial reporting across the entire lifecycle of a clinical trial while ending the need for any post-study reconciliation. Earlier this month, Clinverse introduced ClinSpend™, a new module for aggregating and reporting compliant data to the appropriate entity responsible for OPEN PAYMENTS (formerly know as Sunshine Act) reporting.
DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related health care products. This annual meeting provides thought leaders, decision-makers and patient advocates with the opportunity to collaborate and share knowledge with the top minds in medicine.
In addition to exhibiting at DIA, Clinverse is hosting a free webcast on Wednesday, June 19 at 2:00 pm ET titled “The Sun Has Risen on the Sunshine Act: Understanding the Challenges of Complying with the National Physician Payment Transparency Program.” With over 100 attendees from throughout BioPharma already signed up to attend, the webcast will serve as a foru
Copyright©2012 Vocus, Inc.
All rights reserved